Standard BioTools (LAB)
Nasdaq Market Closed
Standard BioTools Inc. is a life sciences technology company that supplies instruments, consumables and related services used in biomedical research. Its products are designed to help scientists examine biological systems at high resolution, with a focus on tools that support drug discovery, translational medicine and clinical research.
The company is best known for platforms built around mass cytometry and microfluidics. Its CyTOF technology enables single-cell proteomics by allowing researchers to measure many protein markers across individual cells, while its Hyperion imaging systems extend proteomic analysis into tissue samples for spatial biology applications. Standard BioTools also offers genomics systems such as the Biomark X9, which is used for high-throughput genetic analysis and other molecular workflows.
These technologies are used by pharmaceutical companies, biotechnology developers, academic institutions and research laboratories that need reproducible biological data across complex samples. The company’s revenue base includes hardware sales as well as recurring demand for reagents, assays, chips, panels, software and support services connected to its installed instruments.
Standard BioTools operates internationally across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Its market position is tied to long-term growth in precision medicine, immune profiling, oncology research and other areas where researchers require deeper measurement of cells, proteins and genes. As a listed life sciences tools company, Standard BioTools offers investors exposure to the research infrastructure behind biomedical innovation rather than to a single drug candidate.
Last updated
- Market Cap
- 289.68M
- P/E
- 3.7
- P/FCF
- —
- P/S
- 3.36
- Enterprise Value
- 24.21M
- Sector
- Industrials
- Industry
- Laboratory Analytical Instruments
- Address
- 50 MILK STREET, BOSTON, MA, 02109
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AstroNova, Inc. (Nasdaq – ALOT), Open Lending Corporation (Nasdaq – LPRO), Huntsman Corporation (NYSE – HUN), Standard BioTools Inc. (Nasdaq – LAB)
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 289.68M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 24.21M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 3.7
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.52
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.36
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -0.34
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.28
- EPS
- 0.2
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -94.48M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 13.94%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 12.24%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 12.36
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 11.92
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 6.3
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.41M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 0.74
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 21.15M | 23.8M | 19.55M | 21.76M | 20.22M |
| Gross profit | 11.31M | 11.38M | 9.48M | 10.63M | 11.05M |
| Operating income | -12.5M | -24.64M | -32.94M | -25.7M | -26.97M |
| EBITDA | -8.01M | -20.63M | -21.95M | -19.71M | -20.04M |
| Net income | 127.07M | 19.28M | -34.69M | -33.46M | -26.03M |
| Basic EPS | 0.33 | 0.05 | -0.09 | -0.09 | -0.07 |
| Diluted EPS | 0.33 | 0.05 | -0.09 | -0.09 | -0.07 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 639.11M | 567.75M | 539.64M | 556.97M | 579.6M |
| Total liabilities | 77.99M | 143.46M | 139.98M | 132.43M | 125M |
| Total equity | 561.12M | 424.29M | 399.66M | 424.54M | 454.6M |
| Cash & equivalents | 265.77M | 120.86M | 129.42M | 158.62M | 150.88M |
| Current assets | 521.45M | 454.26M | 472.44M | 506.04M | 344.02M |
| Current liabilities | 42.2M | 82.68M | 85.75M | 80.04M | 56.24M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -46.6M | -1.19M | -22.2M | -20.67M | -30.28M |
| Investing cash flow | 191.09M | -8.04M | -6.68M | 27.51M | 14.63M |
| Financing cash flow | -40K | 620K | -112K | 108K | -46K |
| Change in cash | 144.57M | -8.71M | -29.2M | 7.73M | -15.35M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| form 4 | Form 4 — Mackay Sean | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — HIBBS KATHY L | View Filing | |
| form 4 | Form 4 — HIBBS KATHY L | View Filing | |
| form 4 | Form 4 — ELOI FENEL M | View Filing | |
| form 4 | Form 4 — ELOI FENEL M | View Filing | |
| form 4 | Form 4 — Cox Troy | View Filing | |
| form 4 | Form 4 — Cox Troy | View Filing | |
| form 4 | Form 4 — Casdin Eli | View Filing | |
| form 4 | Form 4 — Casdin Eli | View Filing | |
| form 4 | Form 4 — Casdin Eli | View Filing | |
| form 4 | Form 4 — Casdin Eli | View Filing | |
| form 4 | Form 4 — Casdin Eli | View Filing | |
| form 4 | Form 4 — Witney Frank | View Filing | |
| form 4 | Form 4 — Witney Frank | View Filing | |
| form 4 | Form 4 — Witney Frank | View Filing | |
| form 4 | Form 4 — Carey Thomas D. | View Filing | |
| form 4 | Form 4 — Carey Thomas D. | View Filing | |
| edgar index | SCHEDULE 13D — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | SCHEDULE 13D/A — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 425 — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SD — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| form 4 | Form 4 — Egholm Michael | View Filing | |
| form 4 | Form 4 — Mackay Sean | View Filing | |
| form 4 | Form 4 — Kim Hanjoon Alex | View Filing | |
| edgar index | SCHEDULE 13G/A — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | SCHEDULE 13G/A — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 10-Q — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | DEFA14A — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | ARS — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 8-K — STANDARD BIOTOOLS INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| form 4 | Form 4 — Kim Hanjoon Alex | View Filing | |
| form 4 | Form 4 — Kim Hanjoon Alex | View Filing | |
| form 4 | Form 4 — Kim Hanjoon Alex | View Filing | |
| form 4 | Form 4 — Egholm Michael | View Filing | |
| form 4 | Form 4 — Egholm Michael | View Filing | |
| form 4 | Form 4 — Egholm Michael | View Filing | |
| form 4 | Form 4 — Kim Hanjoon Alex | View Filing | |
| form 4 | Form 4 — Kim Hanjoon Alex | View Filing | |
| form 4 | Form 4 — Mackay Sean | View Filing | |
| form 4 | Form 4 — Mackay Sean | View Filing | |
| form 4 | Form 4 — Egholm Michael | View Filing | |
| form 4 | Form 4 — Egholm Michael | View Filing | |
| edgar index | 10-K — STANDARD BIOTOOLS INC. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing | |
| edgar index | 4 — STANDARD BIOTOOLS INC. | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free